PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF PEMBROLIZUMAB (PEMBRO) VERSUS BRENTUXIMAB VEDOTIN (BV) FOR TREATMENT OF RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL): KEYNOTE-204
EHA Library, Pier Luigi Zinzani,
303389
A CASE OF MICROCYTIC ANEMIA WITH PATHOGENIC VARIANTS IN TMPRSS6, F11, MEFV, AND VWF GENES
EHA Library, Davit Babikyan,
298330
A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND EFFICACY OF TAK-079 IN PATIENTS WITH ITP
EHA Library, Jason Homsy,
298362